Dare Bioscience

DARENasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$20.971 M

$1.40 +5.26%

Close of 7 Aug 2026

Revenue

$1.03M

#3498 by revenue

Earnings

-$13.4M

Loss-making

Shares outstanding

14,559,502

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#392CalciMedicaCALC$21.1M
#393NextCureNXTC$21.1M
#394Dare BioscienceDARE$21.0M
#395Neuphoria TherapeuticsNEUP$20.6M
#396Cellectar BiosciencesCLRB$20.5M

Where these numbers come from

Share counts and financials for Dare Bioscience are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.